Mechanisms of inflammation in gout

Arthritis Research and Therapy

Volumn 12, Issue 2, 2010, Pages

  Busso, Nathalie ^a   So, Alexander ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; CRYOPYRIN; CXCL1 CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; URATE; CARRIER PROTEIN; NLRP3 PROTEIN, HUMAN; URIC ACID;

CELL INTERACTION; CELL PROLIFERATION; DENDRITIC CELL; GOUT; LEUKOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PERITONITIS; PROTEIN BINDING; PROTEIN TARGETING; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION; ACUTE DISEASE; ANIMAL; CRYSTALLIZATION; DISEASE MODEL; HUMAN; IMMUNOLOGY; INFLAMMATION; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHAGOCYTOSIS; SECRETION;

ACUTE DISEASE; ANIMALS; CARRIER PROTEINS; CHEMOTAXIS, LEUKOCYTE; CRYSTALLIZATION; DISEASE MODELS, ANIMAL; GOUT; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LEUKOCYTES; PHAGOCYTOSIS; URIC ACID;

EID: 77956994318     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2952     Document Type: Review

References (50)

1. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961, 54:452-460.
2. Kippen I, Klinenberg JR, Weinberger A, Wilcox WR. Factors affecting urate solubility in vitro. Ann Rheum Dis 1974, 33:313-317. 1006264, 4413418, 10.1136/ard.33.4.313.
3. Katz WA, Schubert M. The interaction of monosodium urate with connective tissue components. J Clin Invest 1970, 49:1783-1789. 322667, 5456794, 10.1172/JCI106396.
4. Nakamura Y, Kambe N, Saito M, Nishikomori R, Kim YG, Murakami M, Nunez G, Matsue H. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 2009, 206:1037-1046. 2715029, 19364881, 10.1084/jem.20082179.
5. Ginsberg MH, Kozin F. Mechanisms of cellular interaction with monosodium urate crystals. IgG-dependent and IgG-independent platelet stimulation by urate crystals. Arthritis Rheum 1978, 21:896-903. 10.1002/art.1780210805, 737013.
6. Ortiz-Bravo E, Sieck MS, Schumacher HR. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 1993, 36:1274-1285. 10.1002/art.1780360912, 8216421.
7. Landis RC, Yagnik DR, Florey O, Philippidis P, Emons V, Mason JC, Haskard DO. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002, 46:3026-3033. 10.1002/art.10614, 12428246.
8. Hoffstein S, Weissmann G. Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes. Arthritis Rheum 1975, 18:153-165. 10.1002/art.1780180213, 48382.
9. Kozin F, Ginsberg MH, Skosey JL. Polymorphonuclear leukocyte responses to monosodium urate crystals: modification by adsorbed serum proteins. J Rheumatol 1979, 6:519-526.
10. Nuki G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep 2008, 10:218-227. 10.1007/s11926-008-0036-3, 18638431.
11. Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S, Hylton DM, Rudge JS, Liu-Bryan R, Terkeltaub RA, Yancopoulos GD, Murphy AJ. Hyperalgesia, synovitis, and multiple biomarkers of inflammation are suppressed by IL-1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis 2009, 68:1602-1608. 10.1136/ard.2009.109355, 19528034.
12. Di Giovine FS, Malawista SE, Nuki G, Duff GW. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 1987, 138:3213-3218.
13. di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991, 87:1375-1381. 295177, 2010550, 10.1172/JCI115142.
14. Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004, 50:2273-2280. 10.1002/art.20317, 15248227.
15. Martin WJ, Walton M, Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum 2009, 60:281-289. 10.1002/art.24185, 19116939.
16. Schiltz C, Liote F, Prudhommeaux F, Meunier A, Champy R, Callebert J, Bardin T. Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events. Arthritis Rheum 2002, 46:1643-1650. 10.1002/art.10326, 12115197.
17. Pessler F, Mayer CT, Jung SM, Behrens EM, Dai L, Menetski JP, Schumacher HR. Identification of novel monosodium urate crystal regulated mRNAs by transcript profiling of dissected murine air pouch membranes. Arthritis Res Ther 2008, 10:R64. 2483455, 18522745, 10.1186/ar2435.
18. Getting SJ, Flower RJ, Parente L, de Medicis R, Lussier A, Woliztky BA, Martins MA, Perretti M. Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins. J Pharmacol Exp Ther 1997, 283:123-130.
19. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, Akira S, Rock KL. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006, 116:2262-2271. 1523415, 16886064, 10.1172/JCI28075.
20. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007, 9:R28. 1906806, 17352828, 10.1186/ar2143.
21. So A, De Meulemeester M, Pikhlak A, Yücel E, Richard D, Murphy V, Arulmani U, Sallstig P, Schlesinger N. Canakinumab (ACZ885) vs. triamcinolone acetonide for treatment of acute flares and prevention of recurrent flares in gouty arthritis patients refractory to or contraindicated to NSAIDs and/or colchicine [abstract LB4]. ACR Annual Meeting 2009 2009, Philadelphia: Wiley.
22. Schumacher HR, Sundy J, Terkeltaub R, Knapp HR, Mellis S, Soo Y, King-Davis S, Weinstein S, Radin A. Placebo-controlled study of rilonacept for gout flare prophylaxis during intiation of urate-lowering therapy [abstract 1096]. ACR Annual Meeting 2009 2009, Philadelphia: Wiley.
23. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550. 10.1146/annurev.immunol.021908.132612, 19302047.
24. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265. 10.1146/annurev.immunol.021908.132715, 19302040.
25. Guma M, Ronacher L, Liu-Bryan R, Takai S, Karin M, Corr M. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum 2009, 60:3642-3650. 10.1002/art.24959, 19950258.
26. Joosten LA, Netea MG, Fantuzzi G, Koenders MI, Helsen MM, Sparrer H, Pham CT, Meer JW, Dinarello CA, Berg WB. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1β. Arthritis Rheum 2009, 60:3651-3662. 10.1002/art.25006, 19950280.
27. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241. 10.1038/nature04516, 16407889.
28. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677. 2396588, 18403674, 10.1126/science.1156995.
29. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126. 10.1038/nature06939, 18496530.
30. Dostert C, Guarda G, Romero JF, Menu P, Gross O, Tardivel A, Suva ML, Stehle JC, Kopf M, Stamenkovic I, Corradin G, Tschopp J. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS ONE 2009, 4:e6510. 2714977, 19652710, 10.1371/journal.pone.0006510.
31. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, Tschopp J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452:103-107. 10.1038/nature06664, 18288107.
32. Santos Moreno P, Latore C. Treatment of severe gouty arthritis with etanercept [abstract]. Ann Rheum Dis 2009, 68(Suppl 3):680.
33. Tausche AK, Richter K, Grassler A, Hansel S, Roch B, Schroder HE. Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option. Ann Rheum Dis 2004, 63:1351-1352. 1754753, 15361402, 10.1136/ard.2003.015743.
34. Fiehn C, Zeier M. Successful treatment of chronic tophaceous gout with infliximab (Remicade). Rheumatol Int 2006, 26:274-276. 10.1007/s00296-005-0617-7, 15933855.
35. Terkeltaub R, Baird S, Sears P, Santiago R, Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum 1998, 41:900-909. 10.1002/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K, 9588743.
36. Nishimura A, Akahoshi T, Takahashi M, Takagishi K, Itoman M, Kondo H, Takahashi Y, Yokoi K, Mukaida N, Matsushima K. Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8. J Leukoc Biol 1997, 62:444-449.
37. Hachicha M, Naccache PH, McColl SR. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 1995, 182:2019-2025. 2192242, 7500047, 10.1084/jem.182.6.2019.
38. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511. 10.1038/nri1391, 15229469.
39. Beutler B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 2009, 227:248-263. 2713013, 19120489, 10.1111/j.1600-065X.2008.00733.x.
40. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005, 52:2936-2946. 10.1002/art.21238, 16142712.
41. Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 2006, 177:6370-6378.
42. Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009, 21:38-46. 2723941, 19230638, 10.1016/j.coi.2009.01.009.
43. Murakami Y, Akahoshi T, Hayashi I, Endo H, Kawai S, Inoue M, Kondo H, Kitasato H. Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. Arthritis Rheum 2006, 54:455-462. 10.1002/art.21633, 16447220.
44. Giclas PC, Ginsberg MH, Cooper NR. Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals. J Clin Invest 1979, 63:759-764. 372012, 438335, 10.1172/JCI109360.
45. Russell IJ, Papaioannou C, McDuffie FC, MacIntyre S, Kushner I. Effect of IgG and C-reactive protein on complement depletion by monosodium urate crystals. J Rheumatol 1983, 10:425-433.
46. Fields TR, Abramson SB, Weissmann G, Kaplan AP, Ghebrehiwet B. Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol 1983, 26:249-257. 10.1016/0090-1229(83)90143-5, 6872344.
47. Russell IJ, Mansen C, Kolb LM, Kolb WP. Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface. Clin Immunol Immunopathol 1982, 24:239-250. 10.1016/0090-1229(82)90235-5, 6749358.
48. Serhan CN, Lundberg U, Weissmann G, Samuelsson B. Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. Prostaglandins 1984, 27:563-581. 10.1016/0090-6980(84)90092-3, 6328582.
49. Rae SA, Davidson EM, Smith MJ. Leukotriene B4, an inflammatory mediator in gout. Lancet 1982, 2:1122-1124. 10.1016/S0140-6736(82)92785-4, 6128450.
50. Forrest MJ, Zammit V, Brooks PM. Inhibition of leucotriene B4 synthesis by BW 755c does not reduce polymorphonuclear leucocyte (PMNL) accumulation induced by monosodium urate crystals. Ann Rheum Dis 1988, 47:241-246. 1003492, 2833186, 10.1136/ard.47.3.241.